125 related articles for article (PubMed ID: 17650312)
1. Statistical validation of the criteria for symptom remission in schizophrenia: preliminary findings.
Opler MG; Yang LH; Caleo S; Alberti P
BMC Psychiatry; 2007 Jul; 7():35. PubMed ID: 17650312
[TBL] [Abstract][Full Text] [Related]
2. One-year functional outcomes of naturalistically treated patients with schizophrenia.
Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
[TBL] [Abstract][Full Text] [Related]
3. Patient-based and clinician-based support for the remission criteria in schizophrenia.
Docherty JP; Bossie CA; Lachaux B; Bouhours P; Zhu Y; Lasser R; Gharabawi GM
Int Clin Psychopharmacol; 2007 Jan; 22(1):51-5. PubMed ID: 17159460
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of two alternative schizophrenia remission definitions: relationship to clinical and quality of life outcomes.
Dunayevich E; Sethuraman G; Enerson M; Taylor CC; Lin D
Schizophr Res; 2006 Sep; 86(1-3):300-8. PubMed ID: 16860974
[TBL] [Abstract][Full Text] [Related]
5. Remission after first-episode schizophrenia: results of a long-term follow-up.
Üçok A; Serbest S; Kandemir PE
Psychiatry Res; 2011 Aug; 189(1):33-7. PubMed ID: 21196051
[TBL] [Abstract][Full Text] [Related]
6. Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics.
Wunderink L; Nienhuis FJ; Sytema S; Wiersma D
Schizophr Bull; 2007 May; 33(3):792-6. PubMed ID: 16894026
[TBL] [Abstract][Full Text] [Related]
7. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders.
Helldin L; Kane JM; Karilampi U; Norlander T; Archer T
Schizophr Res; 2007 Jul; 93(1-3):160-8. PubMed ID: 17395430
[TBL] [Abstract][Full Text] [Related]
8. Direct transition to long-acting risperidone--analysis of long-term efficacy.
Kissling W; Heres S; Lloyd K; Sacchetti E; Bouhours P; Medori R; Llorca PM
J Psychopharmacol; 2005 Sep; 19(5 Suppl):15-21. PubMed ID: 16144782
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
Bobes J; Arango C; Garcia-Garcia M; Rejas J;
J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
[TBL] [Abstract][Full Text] [Related]
10. Optimizing the early prediction model for symptomatic remission with short-term treatment for schizophrenia.
Lin CH; Chou LS; Lin CH; Hsu CY; Chen CC; Lane HY
J Clin Psychopharmacol; 2012 Dec; 32(6):773-7. PubMed ID: 23131876
[TBL] [Abstract][Full Text] [Related]
11. Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.
Riedel M; Mayr A; Seemüller F; Maier W; Klingberg S; Heuser I; Klosterkötter J; Gastpar M; Schmitt A; Sauer H; Schneider F; Gaebel W; Jäger M; Möller HJ; Schennach-Wolff R
World J Biol Psychiatry; 2012 Jan; 13(1):30-8. PubMed ID: 21568628
[TBL] [Abstract][Full Text] [Related]
12. Prediction of symptom remission in schizophrenia during inpatient treatment.
Jäger M; Riedel M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Kühn KU; Lemke MR; Rüther E; Buchkremer G; Gastpar M; Bottlender R; Strauss A; Möller HJ
World J Biol Psychiatry; 2009; 10(4 Pt 2):426-34. PubMed ID: 17853260
[TBL] [Abstract][Full Text] [Related]
13. Comparative remission rates of schizophrenic patients using various remission criteria.
Beitinger R; Lin J; Kissling W; Leucht S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1643-51. PubMed ID: 18616969
[TBL] [Abstract][Full Text] [Related]
14. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
Rossi A; Bagalà A; Del Curatolo V; Scapati F; Bernareggi MM; Giustra MG;
Hum Psychopharmacol; 2009 Oct; 24(7):574-83. PubMed ID: 19790173
[TBL] [Abstract][Full Text] [Related]
15. Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?
Schennach-Wolff R; Jäger M; Obermeier M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Kühn KU; Lemke MR; Rüther E; Klingberg S; Gastpar M; Seemüller F; Möller HJ; Riedel M
World J Biol Psychiatry; 2010 Aug; 11(5):729-38. PubMed ID: 20380620
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of remission and recovery in schizophrenia in the Czech Republic.
Prikryl R; Kholova M; Kucerova HP; Ceskova E
Compr Psychiatry; 2013 Oct; 54(7):1111-6. PubMed ID: 23810077
[TBL] [Abstract][Full Text] [Related]
17. Sociodemographic and clinical factors associated with relapse in schizophrenia.
Chabungbam G; Avasthi A; Sharan P
Psychiatry Clin Neurosci; 2007 Dec; 61(6):587-93. PubMed ID: 18081617
[TBL] [Abstract][Full Text] [Related]
18. Relationship of symptomatic remission with quality of life and functionality in patients with schizophrenia.
Karadayi G; Emiroğlu B; Uçok A
Compr Psychiatry; 2011; 52(6):701-7. PubMed ID: 21296345
[TBL] [Abstract][Full Text] [Related]
19. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
[TBL] [Abstract][Full Text] [Related]
20. Psychopharmacotherapy and remission of patients with schizophrenia.
Degmecić D; Pozgain I; Filaković P; Dodig-Curković K; Mihanović M
Coll Antropol; 2009 Jun; 33(2):547-51. PubMed ID: 19662777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]